Clinical Trial Update: Progesterone Augmentation of Nicotine Replacement Therapy Study [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing progesterone augmentation of nicotine replacement therapy for smoking cessation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smokers Smoking Cessation

Drugs mentioned

• Nicotine replacement therapy (nicotine replacement therapy)
• Progesterone augmentation

Snippet

Sponsor: Yale University | Conditions: Smoking Cessation | Phase 4 | Status: COMPLETED | Results posted: 2019-07-23